RadNet, Inc. (RDNT) Scheduled to Post Quarterly Earnings on Tuesday
RadNet, Inc. (NASDAQ:RDNT) is scheduled to issue its quarterly earnings data before the market opens on Tuesday, November 7th. Analysts expect the company to announce earnings of $0.12 per share for the quarter.
RadNet (NASDAQ:RDNT) last announced its quarterly earnings results on Tuesday, August 8th. The medical research company reported $0.11 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.07. The firm had revenue of $230.00 million for the quarter, compared to analysts’ expectations of $230.32 million. RadNet had a net margin of 1.04% and a return on equity of 19.98%. The company’s revenue was up 5.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.09 EPS. On average, analysts expect RadNet to post $0.36 EPS for the current fiscal year and $0.5 EPS for the next fiscal year.
RadNet, Inc. (NASDAQ RDNT) opened at 10.60 on Tuesday. The firm has a market cap of $501.02 million, a PE ratio of 55.79 and a beta of 0.95. The stock’s 50 day moving average is $11.21 and its 200 day moving average is $8.62. RadNet, Inc. has a 12 month low of $5.25 and a 12 month high of $11.90.
TRADEMARK VIOLATION WARNING: “RadNet, Inc. (RDNT) Scheduled to Post Quarterly Earnings on Tuesday” was originally posted by American Banking News and is owned by of American Banking News. If you are accessing this report on another site, it was illegally stolen and republished in violation of United States & international trademark & copyright law. The legal version of this report can be read at https://www.americanbankingnews.com/2017/10/31/radnet-inc-rdnt-scheduled-to-post-quarterly-earnings-on-tuesday.html.
In other news, major shareholder Sandy Nyholm Kaminsky sold 1,100,000 shares of RadNet stock in a transaction dated Tuesday, October 3rd. The stock was sold at an average price of $10.95, for a total value of $12,045,000.00. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director David L. Swartz sold 25,000 shares of RadNet stock in a transaction dated Thursday, September 7th. The shares were sold at an average price of $10.98, for a total value of $274,500.00. Following the completion of the transaction, the director now directly owns 274,108 shares in the company, valued at $3,009,705.84. The disclosure for this sale can be found here. Over the last three months, insiders sold 1,236,900 shares of company stock worth $13,452,504. 9.36% of the stock is owned by corporate insiders.
RadNet Company Profile
RadNet, Inc is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. As of December 31, 2016, the Company operated directly or indirectly through joint ventures, 305 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island.
Receive News & Ratings for RadNet Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet Inc. and related companies with MarketBeat.com's FREE daily email newsletter.